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Abstract Numerous bioethical recommendations are now available in the complex process of 
communication with cancer patients. In this review, we have focused on the complex 
process of managing patients with different types of oncologic digestive diseases, 
immediately after the diagnosis is made.  
We have analyzed the literature data on the topic. MEDSCAPE and PubMed 
databases have been studied. Issues such as telling the truth to patients with digestive 
cancer, the physician's responsibility in the psychological management of patients and 
their relatives, the nurses’ duties, the consented death, the practice of euthanasia and 
physician-assisted suicide (PAS) as well as the clinical research have been the main 
targets of our study. 
Keywords  ethics, management, digestive cancers 
Highlights  Communication with the cancer patient about the development of the disease and the 
oncologic management is the key to a successful oncologic therapy. 
 Cultural statements, laws and ethical rules have been largely developed and standardized 
lately to create models of behavior for physicians, nurses and patient's family members, 
to maximize the comfort and the life quality of cancer patients.   
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Introduction 
Bioethical rules should guide physicians in the 
communication process with cancer patients. In this 
review, we have focused on the complex process of 
communication with patients suffering from different 
types of oncologic digestive diseases, immediately after 
diagnosis. Communicating the information about 
diagnosis, treatment and prognosis to patients with 
gastrointestinal cancer is the main issue concerning the 
ethical aspect of the studied pathology (1). For more than 
25 years, different committees composed of experts in 
psychology, researchers in the field of oncology, patient’s 
advocates and physicians have been preoccupied and 
made efforts in creating a guideline to follow when it 
comes to cancer patients. Throughout time, the central 
ethical aspects studied have been the following: telling the 
truth to the patient, the physician's responsibility for the 
psychological management of patients and their relatives, 
the nurses’ duties, the consent to death (2), the practice of 
euthanasia, the physician-assisted suicide (PAS) (3) and 
the clinical research (4). 
The present review relates to the available data in the 
literature regarding the ethics in oncologic digestive 
diseases. MEDSCAPE and PubMed databases have been 
studied, and terms such as ethics and gastrointestinal 
cancer have been the search engines. From the entire 
database, thirteen studies have been selected. Issues such 
as: telling the truth to the patient, the physician's 
responsibility for the psychological management of 
patients and their relatives, the nurses’ duties, the consent 
to death, the practice of euthanasia, the physician-assisted 
suicide (PAS) and the clinical research have been the 
main topics studied. 
Discussions 
 Telling the truth to patients with digestive cancers 
Attitudes and practices of truth-telling to patients 
diagnosed with digestive cancer have changed 
substantially in the past decades (5). In clinical practice, 
dilemmas of whether, when and how to tell the truth to 
patients are sometimes very difficult to solve. Cultural 
and individual differences interfere and these aspects have 
magnified the difficulties in the communication with 
digestive cancer patients. The prognosis of the disease can 
influence the anxiety of patients when coping with 
digestive cancer (6). The main approved approach related 
to these patients is unitary but it is influenced by digestive 
cancer location and stage. Patients playing an active role 
in the diagnosis of digestive cancer are nowadays the first 
target of screening programs. Making people aware of the 
importance of detecting digestive cancer in the early 
stages is the concern of our current society. Spreading the 
information regarding the screening procedure for 
colorectal, esophageal or stomach cancer can lead in the 
following decades not only to a better communication 
with the cancer patient but also to a decrease in the 
incidence of oncologic digestive diseases. The willingness 
of patients to participate in screening programs makes it 
easier for the physician to communication the subsequent 
diagnosis. Patients concerned about their health are more 
focused on "what to do next" than on the gravity of the 
moment. They can play an active role in the diagnosis and 
treatment management. However, the majority of patients 
are discovered beyond the screening programs. To better 
cope with the diagnosis, people need to preserve hope. 
The means of treatment, the evolutionary and the 
prognostic data should be correctly presented to patients 
to ensure that the accurate information is given and the 
right choice is made by the patient. However, ethnical 
origins, religious beliefs, cultural differences and legal 
regulations should be also respected. 
 The physician's responsibility in the psychological 
management of patients and their relatives 
Advances in the psychological research have changed 
the way of thinking about health and illness. The 
biopsychosocial model relates to health and disease as the 
product of a multitude of factors including biological 
characteristics (such as genetic predisposition), behavioral 
factors (such as lifestyle, stress, health beliefs) and social 
conditions (such as cultural influences, family 
relationships and social support) (7). This 
conceptualization of health and illness has many scientific 
and practical benefits. Following this concept, a lot of 
patients can reduce their risk of developing major medical 
problems, receive adequate treatment and reduce health-
related costs when asking for the treatment to an 
interdisciplinary team including behavioral healthcare 
providers (8-10). However, in the field of oncology, 
things are more complicated. Facing the diagnosis of 
cancer causes severe distress. Like the patient, the family 
also feels the emotional discomfort of the patient. Patients 
feel distressed during the onset, the course and the 
outcome of the disease. The psychological support for the 
patient and family members could minimize the impact of 
the illness and can also contribute to an improved life 
quality for both patients and relatives involved in 
caregiving. 
Physicians are focused on improving collaboration 
and the illness perception among the family members, 
patients and other healthcare professionals. In all this 
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period, it is essential to support the patient and the family 
throughout the course of the disease and the cancer 
treatment. The therapeutic alliance with the family that 
should be informed about all aspects of the digestive 
cancer patient is a powerful tool to improve. Besides the 
life quality of the patient, the psychological distress of the 
family members who are involved in the patient’s support 
should be improved. The physicians’ goal is to help the 
patient's family face the anxiety and fears for patients 
with digestive cancers and also, the capacity to meet 
everyday problems (11). The impossibility of self-feeding 
in eso-gastric cancers, the presence of stomata for easier 
feeding, the presence of stomata for intestinal evacuation 
are challenging for patients. One should plan meetings to 
inform patients and home-care providers to accept the 
new disability and to monitor the functionality of the 
devices used. Special communication skills are required 
to meet the family’s expectations during the discussions 
regarding the aspects of the patient's everyday life (12). 
Before meeting the family, it is essential to know the 
details regarding the patient's family, such as 
composition, residence, the living standards, the lifestyle 
and the social life and, whenever possible, the aspects 
about culture, values and spiritual beliefs. These aspects 
will make it easier to cooperate when it comes to the 
material and psychological resources throughout the 
disease and what expectations they have from doctors and 
medicine altogether (13). Planning whom to invite to a 
meeting and the preparation of the meeting along with the 
proper environment for it are issues that should be solved 
beforehand. The physician should then investigate with 
empathy all the emotions and beliefs that run in the family 
and try to support the positive feelings of pain sharing. 
Moreover, the physician should allow time to express the 
negative feelings of anxiety and to advise the patient and 
the family to deal with them in everyday life and the 
change in habits required by the illness. However, the 
patient should remain the core of the conversation. The 
physician should emphasize the suffering, the 
communication difficulties, the commitment to active 
participation to treatment and the influence of emotional 
distress on relatives. Counseling experience proved that 
physicians should always be aware of the patient's 
constant shifts, from the expectation of endless support 
from the family members to the effort of being 
autonomous and independent in the management of the 
disease, and act consequently (12). 
 Nurses’ responsibilities  
The management of cancer patients required 
specialized healthcare providers. An innovative class of 
nurses to attend patients with gastrointestinal cancer is 
now available in some specialized centers. The nurse's 
role in caring for digestive cancer patients includes 
knowledge on the oncologic disease pathophysiology, risk 
factors identification, detection methods, clinical features, 
available treatments, conventional and integrative holistic 
nursing interventions and community resources. For 
digestive cancer patients, nurses should be skilled in 
monitoring and restoring the damaged functionality of the 
devices used. They should inform patients and family 
members on everyday use of tools and their cleaning and 
should also tell them about possible side effects (13, 14). 
 The consent to death, the practice of euthanasia and 
physician-assisted suicide (PAS) 
Physician-assisted suicide (PAS) is the most exciting 
issue of present times (3, 15). Religious condemnation 
and sometimes moral disapproval of suicide by the 
society were associated with its criminalization in most 
societies before the beginning of modern times (16, 17). 
However, opinions regarding suicide have changed during 
the 19th and the 20th century, which coincide with the 
development of modern psychiatry, as an autonomous 
discipline. In this field, the practitioners could investigate, 
diagnose and treat anxiety, depression and other ailments 
leading to suicide. The achievements in the psychiatric 
field referred to mental illness opposite to the hypothesis 
that consenting to death in end-stage diseases is related to 
a psychiatric disorder or is determined by social or 
psychological forces. These issues once contributed to the 
decriminalization of suicide (18). In 1967, the wave of 
accepting the idea of end-of-life choice appeared, even if 
dominated by skepticism among the society and the 
medical authority (19). 
Along with the specialist’s evaluation of the medical 
reasons for the patient's end-of-life decision, an 
exhaustive psychiatric evaluation is required when 
confronted with a request for PAS. Another concern of 
the authorities, besides the elimination of possible mental 
illness, was the idea that PAS can become a practice, 
especially in vulnerable populations. Targets such as 
increasing the patient's autonomy and adhering to 
professional liabilities, as well as promoting for additional 
research that focuses more directly on the patient-centered 
perspective, are still imposed. Nowadays, PAS is legal in 
4 states of the US and also in the Nederland.  Even though 
legitimate, the issue is not without discomfort for 
physicians. Even the phrase itself "physician-assisted 
suicide" is controversial. For example, Oregon's "Death 
with Dignity Act" clearly states the physicians’ role as the 
primary gatekeepers of assisted suicide.  The physicians’ 
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duties are the insurance of the fact that the disease is 
terminal, with a prognosis of maximum six months and 
only if the patient requesting PAS acts voluntarily, being 
capable of making decisions and being well informed 
about his medical condition. Even under such conditions, 
physicians may feel uncomfortable to assist PAS.  
Besides the communication with the patient's physician 
regarding all aspects of treatment and behavior when 
facing digestive cancer, the psychiatrist's role as an expert 
includes the evaluation of his decision-making capacity 
and the clarification of discussions among treatment 
participants (the physician, the family and, last but not 
least, the patient) to minimize the possibility of undue 
influence on a patient's ultimate decision (20). 
 Clinical research 
The newest oncologic therapies have led to an 
increase of the mean survival time for patients with 
advanced digestive cancer, for example almost fourfold 
longer than expected with the best supportive care in 
CRC. This good evolution was accomplished due to the 
combination of chemotherapy and targeted biologic 
agents. However, the identification of KRAS mutations 
proved that the newest agents are targeting epidermal 
growth factor receptors, such as cetuximab and 
panitumumab, and therefore are not beneficial to patients 
with mutations. This process of understanding what is of 
maximum interest for the targeted therapy in colorectal 
cancer has taken years (21). The time spent from the 
presentation and publication of small, retrospective phase 
II studies to widespread acceptance of the KRAS 
predictive value and changes in oncologic guidelines was 
lengthy enough. The process of data disclosure regarding 
KRAS status and the treatment of advanced CRC patients 
was effective in permitting timely decisions regarding the 
ongoing publicly funded clinical trials and, whether or not 
such decisions were rational and ethical is still 
controversial (22). 
Conclusions 
The ethical aspects of the oncologic digestive diseases 
are fundamental in managing patients. The ability of 
physicians involved in diagnosis and treatment, the 
support of psychiatrists, the interaction and 
communication with family members, the support of 
nurses and the law regulations in terms of allowing 
assisted death are the pillars of an excellent ethical 
attitude. The differences in culture, religious beliefs and 
socioeconomic status make it very hard to have a global 
approach. However, ethical rules should guide the 
physician's decisions in attending digestive cancer 
patients. 
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